ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,602.99
0.30%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Precigen Inc (PGEN)

  7. Precigen Inc (PGEN) Noticias

PGEN Precigen Inc

1.41
0.01 (0.71%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Precigen Inc PGEN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.01 0.71% 1.41 23:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.40 1.39 1.44 1.41 1.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202409:20PRNUSPrecigen to Present Late-breaking Abstract for Pivotal Phase..
24/4/202408:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
28/3/202415:05PRNUSPrecigen and Recurrent Respiratory Papillomatosis Foundation..
19/3/202415:05PRNUSPrecigen Reports Full Year 2023 Financial Results and..
19/3/202406:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
12/3/202415:05PRNUSPrecigen to Participate in a Fireside Chat Hosted by Cantor..
05/3/202415:05PRNUSPrecigen to Announce Fourth Quarter and Full Year 2023..
27/2/202412:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:25EDGAR2Form 8-K - Current report
06/2/202415:05PRNUSPrecigen to Participate in the Oppenheimer 34th Annual..
17/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
16/1/202407:05PRNUSPrecigen Receives Orphan Drug Designation for PRGN-2012 for..
08/1/202407:39EDGAR2Form 8-K - Current report
08/1/202407:30PRNUSPrecigen Highlights Pipeline Updates to be Presented at the..
29/12/202316:26EDGAR2Form S-3 - Registration statement under Securities Act of..
18/12/202315:05PRNUSPrecigen to Present at the 42nd Annual J.P. Morgan..
29/11/202315:05PRNUSPrecigen to Participate in the JMP Securities Hematology and..
09/11/202316:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202316:07EDGAR2Form 8-K - Current report
09/11/202315:55PRNUSPrecigen Reports Third Quarter 2023 Financial Results and..
07/11/202315:05PRNUSPrecigen to Participate in the Stifel 2023 Healthcare..
19/9/202315:05PRNUSPrecigen to Participate in Upcoming Leading Investor and..
25/8/202318:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202317:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202320:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202320:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202320:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202320:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202318:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202307:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202307:15EDGAR2Form 8-K - Current report
09/8/202307:00PRNUSPrecigen Reports Second Quarter and First Half 2023..
09/8/202306:05PRNUSPrecigen Announces FDA Confirmation that the Ongoing Phase..
04/8/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202318:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202318:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202315:05PRNUSPrecigen to Announce Second Quarter and First Half 2023..

Su Consulta Reciente

NASDAQ
PGEN
Precigen
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados